- Report
- June 2025
- 294 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 293 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 182 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 244 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 312 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 262 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 184 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 193 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 456 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 213 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 374 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 224 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 488 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 235 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 578 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 577 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 419 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 384 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- February 2025
- 150 Pages
Global
From €2918EUR$3,250USD£2,485GBP
€4355EUR$4,850USD£3,708GBP
- Report
- February 2025
- 144 Pages
Global
From €2693EUR$2,999USD£2,293GBP

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more